{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:03:38Z","timestamp":1790737418620,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["MGU0489"],"award-info":[{"award-number":["MGU0489"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["812890"],"award-info":[{"award-number":["812890"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["22855"],"award-info":[{"award-number":["22855"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.phrs.2023.107005","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:41:00Z","timestamp":1700527260000},"page":"107005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation"],"prefix":"10.1016","volume":"198","author":[{"given":"Jianmin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Oggero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cecconello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesmond","family":"Dalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedayatullah","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hjiej Andaloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra","family":"Sanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas EN","family":"Jonassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Perretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2023.107005_bib1","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2023.107005_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega-G\u00f3mez","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2023.107005_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Mol. Asp. Med."},{"issue":"11","key":"10.1016\/j.phrs.2023.107005_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution pharmacology: opportunities for therapeutic innovation in inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2023.107005_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","author":"Qin","year":"2022","journal-title":"Br. J. Pharm."},{"issue":"8","key":"10.1016\/j.phrs.2023.107005_bib6","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.151.8.4306","article-title":"Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody","volume":"151","author":"Perretti","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2023.107005_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","article-title":"Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation","volume":"63","author":"Perretti","year":"2023","journal-title":"Annu. Rev. Pharm. Toxicol."},{"issue":"12","key":"10.1016\/j.phrs.2023.107005_bib8","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.4049\/jimmunol.172.12.7669","article-title":"An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family","volume":"172","author":"Ernst","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2023.107005_bib9","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1182\/blood-2005-08-3099","article-title":"Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement","volume":"107","author":"Hayhoe","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.phrs.2023.107005_bib10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1096\/fj.99-0602fje","article-title":"Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment","volume":"14","author":"D'Amico","year":"2000","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.phrs.2023.107005_bib11","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.jacc.2019.03.503","article-title":"Pro-angiogenic macrophage phenotype to promote myocardial repair","volume":"73","author":"Ferraro","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.107005_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1096\/fj.04-2178fje","article-title":"Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct","volume":"19","author":"Gavins","year":"2005","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.phrs.2023.107005_bib13","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1096\/fj.01-0196com","article-title":"Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action","volume":"15","author":"La","year":"2001","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.phrs.2023.107005_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02176.x","article-title":"Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)","volume":"168","author":"Qin","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.107005_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2014.11.012","article-title":"Cardioprotective potential of annexin-A1 mimetics in myocardial infarction","volume":"148","author":"Qin","year":"2015","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/jpet.108.145821","article-title":"A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects","volume":"328","author":"Hecht","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2023.107005_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jacbts.2021.07.007","article-title":"Selective FPR2 agonism promotes a proresolution macrophage phenotype and improves cardiac structure-function post myocardial infarction","volume":"6","author":"Garc\u00eda","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.phrs.2023.107005_bib18","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1476-5381.1993.tb12843.x","article-title":"Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1","volume":"108","author":"Cirino","year":"1993","journal-title":"Br. J. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2023.107005_bib20","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.4049\/jimmunol.1203000","article-title":"Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2\/lipoxin A4 receptor","volume":"190","author":"Dalli","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2023.107005_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175786","article-title":"Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide","volume":"12","author":"Perretti","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1189\/jlb.1107765","article-title":"Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1\/lipoxin A4 receptor: implications for resolution of inflammation","volume":"84","author":"El Kebir","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2023.107005_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SHK.0000000000000963","article-title":"The antimalarial drug artesunate attenuates cardiac injury in A rodent model of myocardial infarction","volume":"49","author":"Khan","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2023.107005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103974","article-title":"MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis","volume":"79","author":"Pistorius","year":"2022","journal-title":"EBioMedicine"},{"issue":"52","key":"10.1016\/j.phrs.2023.107005_bib25","doi-asserted-by":"crossref","first-page":"18685","DOI":"10.1073\/pnas.1410938111","article-title":"Nonredundant protective properties of FPR2\/ALX in polymicrobial murine sepsis","volume":"111","author":"Gobbetti","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib26","first-page":"152","article-title":"A flow cytometric method for determination of the blood neutrophil fraction in rats","volume":"48","author":"Skrajnar","year":"2009","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2023.107005_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2023.107005_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nat. Med."},{"issue":"29","key":"10.1016\/j.phrs.2023.107005_bib29","doi-asserted-by":"crossref","first-page":"24690","DOI":"10.1074\/jbc.M112.377101","article-title":"Annexin A1 interaction with the FPR2\/ALX receptor: identification of distinct domains and downstream associated signaling","volume":"287","author":"Bena","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.107005_bib30","article-title":"Structural basis of ligand binding modes at the human formyl peptide receptor 2","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.107005_bib31","article-title":"Structure of formylpeptide receptor 2-G","volume":"11","author":"Zhuang","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.107005_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28586-0","article-title":"Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2","volume":"13","author":"Zhuang","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrrheum.2016.193","article-title":"Immune resolution mechanisms in inflammatory arthritis","volume":"13","author":"Perretti","year":"2017","journal-title":"Nat. Rev. Rheuma"},{"issue":"9","key":"10.1016\/j.phrs.2023.107005_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14728222.2017.1364363","article-title":"Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases","volume":"21","author":"Perucci","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"7","key":"10.1016\/j.phrs.2023.107005_bib35","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.phrs.2023.107005_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib37","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.phrs.2023.107005_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155294","article-title":"VEGF-A in cardiomyocytes and heart diseases","volume":"21","author":"Braile","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib39","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI124635","article-title":"Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation","volume":"130","author":"McArthur","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","article-title":"Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice","volume":"9","author":"Misharin","year":"2014","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1582-4934.2005.tb00354.x","article-title":"L-selectin: mechanisms and physiological significance of ectodomain cleavage","volume":"9","author":"Smalley","year":"2005","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2010-11-321406","article-title":"Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites","volume":"118","author":"Tang","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0003-4975(95)00424-J","article-title":"Role of selectins in myocardial ischemia-reperfusion injury","volume":"60","author":"Lefer","year":"1995","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.88.2.649","article-title":"Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium","volume":"88","author":"Ma","year":"1993","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1172\/JCI119561","article-title":"Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein","volume":"100","author":"Zouki","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2023.107005_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-5223(99)70064-4","article-title":"Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass","volume":"118","author":"Ilton","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9 Suppl","key":"10.1016\/j.phrs.2023.107005_bib47","first-page":"II364","article-title":"Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans","volume":"94","author":"Gali\u00f1anes","year":"1996","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.phrs.2023.107005_bib48","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/hc4601.099403","article-title":"In vivo myocardial protection from ischemia\/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone","volume":"104","author":"Yue Tl","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2023.107005_bib49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1189\/jlb.0906545","article-title":"Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils","volume":"82","author":"Orr","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1189\/jlb.0809532","article-title":"The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies","volume":"87","author":"Hol","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2023.107005_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1476-5381.2009.00367.x","article-title":"A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC\/CXCL1 and LIX\/CXCL5","volume":"158","author":"Vieira","year":"2009","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2023.107005_bib52","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.ATV.19.9.2141","article-title":"Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents","volume":"19","author":"Zacharowski","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"20","key":"10.1016\/j.phrs.2023.107005_bib53","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.15212","article-title":"Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology","volume":"177","author":"Perretti","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2023.107005_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0300-9572(02)00003-5","article-title":"Strain specific differences in a cardio-pulmonary resuscitation rat model","volume":"53","author":"Ebmeyer","year":"2002","journal-title":"Resuscitation"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:48:15Z","timestamp":1760914095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823003614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"alternative-id":["S1043661823003614"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.107005","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.107005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107005"}}